Wright Medical (NSDQ:WMGI) said it’s planning a private placement for $200 million worth of senior notes due 2017.
wrightmedical
Dana-Farber shuffles the deck | Personnel Moves
Hip: Feds probe Wright Medical’s Profemur metal hip implants
Wright Medical (NSDQ:WMGI) unveiled in its latest earnings report that the medical device company received a subpoena from the U.S. Attorney’s Office for the Western District of Tennesee requesting records relating to the its suite of metal hip implants.
Wright Medical sought to block Smith & Nephew’s metal-on-metal hip implant
Ortho outlook: Device makers gain as Biomet reports 7% increase in U.S. sales
Orthopedic device makers posted Wall Street gains today following the release of privately owned Biomet’s preliminary 4th quarter and full-year financial results.
Warsaw, Ind.-based Biomet, considered a beacon of larger trends in orthopedics, said it expects to report a 7% increase in U.S. sales and a 12% increase in international sales for the 4th quarter, although European sales declined 8%.
FDA panel: Avoid metal-on-metal hips but don’t panic
FDA panelists last week agreed that, although there are no circumstances in which metal-on-metal hip implants are better than the alternatives, the medical devices should be left in patients who aren’t experiencing any problems.
Wright Medical doubles Wall Street’s forecast for Q1, shares soar
Wall Street showed some love for Wright Medical Group (NSDQ:WMGI) following the company’s Q1 report, in which adjusted earnings doubled analysts’ expectations.
GMI Ratings adds Boston Scientific to risky bet list | Wall Street Beat
A rating agency specializing in evaluating risky investments added Boston Scientific (NYSE:BSX) to its "Risk List," citing the ongoing fallout from its ill-starred Guidant buyout, its accounting and governance practices and how it pays its executives.
Edwards to re-state financials | Wall Street Beat
Edwards Lifesciences (NYSE:EW) said it will re-state its financial results for the first 3 quarters of 2011, “due to certain technical errors in the balance sheets and cash flow statements for these interim periods.”
The Irvine, Calif.-based heart valve maker said the errors involve the mis-statement of short-term investments as cash & equivalents, plus the way it treated tax benefits from stock plans.
Is Boston Scientific in line for a private equity takeover? | Wall Street Beat
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.
Wright Medical beats The Street amid sagging sales
Wright Medical Group Inc. (NSDQ:WMGI) posted a Wall-Street-beating quarter amid declining sales and an earnings forecast below analysts’ estimates for 2012.
The Arlington, Tenn.-based orthopedics company reported profits of $1.2 million, or 3 cents per diluted share, on sales of $126.9 million during the 3 months ended Dec. 31, 2011.